Literature DB >> 15309590

Cancer patients with septic shock: mortality predictors and neutropenia.

Carlos J Regazzoni1, Célica Irrazabal, Carlos M Luna, Juan J Poderoso.   

Abstract

GOALS OF WORK: To study outcome and its predictive factors in cancer patients admitted to the ICU with septic shock, and the implications of neutropenia as a risk factor in this advanced stage of systemic inflammatory response. PATIENTS AND METHODS: A prospective consecutive observational cohort study was conducted in 73 adults with cancer and septic shock admitted to the ICU at the Cancer Medical Center associated with the University of Buenos Aires. MAIN
RESULTS: The mortality rate from septic shock was 53.4% (95%CI 41.9 to 64.8%). The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score on admission, the mean number of organ dysfunctions on admission or during the ICU stay, liver dysfunction, respiratory dysfunction, and the need for mechanical ventilation were predictive of mortality in a univariate analysis. Neutropenia was not associated with a worse prognosis in terms of mortality (56%) or mean days of ICU stay (6.64 days) in comparison with nonneutropenic patients (52.1% and 6.8 days) in the univariate analysis. In the logistic regression model only the need for mechanical ventilation and liver dysfunction remained independent predictors of mortality.
CONCLUSIONS: Septic shock among cancer patients admitted to the ICU has a mortality rate similar to that reported for mixed populations, and it is particularly increased when hepatic or respiratory dysfunction develop. Neutropenia on admission does not seem to modify outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15309590     DOI: 10.1007/s00520-004-0667-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  28 in total

1.  Predictive factors of death in primary lung cancer patients on admission to the intensive care unit.

Authors:  S Boussat; T El'rini; A Dubiez; A Depierre; F Barale; G Capellier
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

2.  Influence of white blood cells on the fibrinolytic response to sepsis: studies of septic patients with or without severe leucopenia.

Authors:  M A Haj; I J Neilly; L A Robbie; G D Adey; B Bennett
Journal:  Br J Haematol       Date:  1995-07       Impact factor: 6.998

3.  Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures.

Authors:  F Blot; M Guiguet; G Nitenberg; B Leclercq; B Gachot; B Escudier
Journal:  Eur J Cancer       Date:  1997-06       Impact factor: 9.162

4.  Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.

Authors:  C M Luna; A Videla; J Mattera; C Vay; A Famiglietti; P Vujacich; M S Niederman
Journal:  Chest       Date:  1999-10       Impact factor: 9.410

5.  Outcomes of critically ill cancer patients in a university hospital setting.

Authors:  J P Kress; J Christenson; A S Pohlman; D R Linkin; J B Hall
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

Review 6.  Circulatory shock.

Authors:  A Bogolioubov; D L Keefe; J S Groeger
Journal:  Crit Care Clin       Date:  2001-07       Impact factor: 3.598

7.  Severity of illness scores: are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study.

Authors:  F Blot; C Cordonnier; A Buzin; G Nitenberg; B Schlemmer; S Bastuji-Garin
Journal:  Crit Care Med       Date:  2001-11       Impact factor: 7.598

8.  Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy.

Authors:  D P Schuster; J M Marion
Journal:  Am J Med       Date:  1983-09       Impact factor: 4.965

Review 9.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome.

Authors:  J C Marshall; D J Cook; N V Christou; G R Bernard; C L Sprung; W J Sibbald
Journal:  Crit Care Med       Date:  1995-10       Impact factor: 7.598

10.  Adult respiratory distress syndrome in neutropenic patients.

Authors:  M D Laufe; R H Simon; A Flint; J B Keller
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

View more
  12 in total

1.  Timing to antibiotic therapy in septic oncologic patients presenting without hypotension.

Authors:  Kathleen Morneau; Gary B Chisholm; Frank Tverdek; Jeffrey Bruno; Katy M Toale
Journal:  Support Care Cancer       Date:  2017-05-26       Impact factor: 3.603

Review 2.  Risk assessment models to estimate cancer probabilities.

Authors:  Constance M Johnson; Derek Smolenski
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

3.  Prevalence of acute liver dysfunction and impact on outcome in critically ill patients with hematological malignancies: a single-center retrospective cohort study.

Authors:  Andry Van de Louw; Kathleen Twomey; Nicholas Habecker; Kevin Rakszawski
Journal:  Ann Hematol       Date:  2020-09-12       Impact factor: 3.673

4.  Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Authors:  Dominique M Vandijck; Dominique D Benoit; Pieter O Depuydt; Fritz C Offner; Stijn I Blot; Anna K Van Tilborgh; Joke Nollet; Eva Steel; Lucien A Noens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

5.  N-terminal pro-brain natriuretic peptide as an early prognostic factor in cancer patients developing septic shock.

Authors:  Djamel Mokart; Antoine Sannini; Jean-Paul Brun; Marion Faucher; Didier Blaise; Jean-Louis Blache; Catherine Faucher
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

6.  Outcome of severe infections in afebrile neutropenic cancer patients.

Authors:  Ksenija Strojnik; Ksenija Mahkovic-Hergouth; Barbara Jezersek Novakovic; Bostjan Seruga
Journal:  Radiol Oncol       Date:  2016-02-10       Impact factor: 2.991

7.  Analysis of cancer patients admitted to intensive care unit.

Authors:  Yakup Aksoy; Ayhan Kaydu; Omer Fatih Sahin; Cem Kivilcim Kacar
Journal:  North Clin Istanb       Date:  2017-01-25

8.  Cancer patients with community-acquired pneumonia treated in intensive care have poorer outcomes associated with increased illness severity and septic shock at admission to intensive care: a retrospective cohort study.

Authors:  Ricardo J P José; Ali O Mohammed; James J P Goldring; Rachel C Chambers; Jeremy S Brown; Banwari Agarwal
Journal:  Pneumonia (Nathan)       Date:  2015-12-01

9.  A 12-year study evaluating the outcomes and predictors of mortality in critically ill cancer patients admitted with septic shock.

Authors:  Wedad B Awad; Lama Nazer; Salam Elfarr; Maha Abdullah; Feras Hawari
Journal:  BMC Cancer       Date:  2021-06-16       Impact factor: 4.430

10.  Characteristics and outcomes of cancer patients in European ICUs.

Authors:  Fabio Silvio Taccone; Antonio A Artigas; Charles L Sprung; Rui Moreno; Yasser Sakr; Jean-Louis Vincent
Journal:  Crit Care       Date:  2009-02-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.